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ABSTRACT
The essential mycobacterial transcriptional regulators RbpA and CarD act to modulate transcription
by associating to the initiation complex and increasing the flux of transcript production. Each of
these factors interacts directly with the promoter
DNA template and with RNA polymerase (RNAP)
holoenzyme. We recently reported on the energetics of CarD-mediated open complex stabilization on
the Mycobacterium tuberculosis rrnAP3 ribosomal
promoter using a stopped-flow fluorescence assay.
Here, we apply this approach to RbpA and show that
RbpA stabilizes RNAP-promoter open complexes
(RPo ) via a distinct mechanism from that of CarD. Furthermore, concentration-dependent stopped-flow experiments with both factors reveal positive linkage
(cooperativity) between RbpA and CarD with regard
to their ability to stabilize RPo . The observation of
positive linkage between RbpA and CarD demonstrates that the two factors can act on the same transcription initiation complex simultaneously. Lastly,
with both factors present, the kinetics of open complex formation is significantly faster than in the presence of either factor alone and approaches that of E.
coli RNAP on the same promoter. This work provides
a quantitative framework for the molecular mechanisms of these two essential transcription factors
and the critical roles they play in the biology and
pathology of mycobacteria.
INTRODUCTION
The regulation of gene expression serves as a gateway between genotype and phenotype. By modulating the output of specific genes, cells tune their molecular makeup to
* To

best suit environmental conditions. Much of this regulation
is enacted by modulating the rates of transcription initiation to control the flux of RNA production. In bacteria,
the basal transcriptional machinery is composed of RNA
polymerase holoenzyme which consists of a catalytic core
enzyme (␤␤’␣2 ) and a dissociable sigma factor () that
directs promoter recognition. Transcription initiation proceeds via the binding of RNAP holoenzyme to promoter
DNA to form closed complex (RPc ) followed by the spontaneous unwinding of approximately a turn of DNA to form
open complex (RPo ). In RPo , the single-stranded DNA
template is correctly positioned in the polymerase active
site, incoming ribonucleotides may bind and RNA polymerization may ensue. The polymerization of the initial ribonucleotides leads to promoter escape, the formation of a stable elongation complex and the production of transcript. In
Escherichia coli, transcription initiation mechanisms have
been well-studied and multiple kinetic intermediates have
been identified between the initial DNA-holoenzyme closed
complex and open complex (1). These details are of crucial
importance in understanding the structural transitions that
the complexes go through during the isomerization to open
complex. However, a minimal kinetic scheme that describes
promoter binding and opening in two reversible steps (R+P
↔ RPc ↔ RPo ) has proven to be a useful and practical starting point when investigating mechanisms of open-complex
formation and regulation (2).
The regulation of transcription initiation involves factordependent tuning of the stabilities of transcription intermediates and the rates of interconversion between these states.
Examples include modulation of polymerase-promoter
affinity, changing the equilibrium between RPc and RPo
and influencing the rate of NTP-dependent promoter escape (3–5). It has recently become apparent that initiation
in Mycobacterium tuberculosis (Mtb) is controlled via mechanisms that are distinct from those found in E. coli. For example, mycobacteria lack Fis (6), DksA (7) and AT-rich up-
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stream activating elements (8,9). Furthermore, mycobacteria possess unique transcription factors not found in E. coli
including CarD (10–12) and RbpA (13–15).
CarD is an RNAP- and DNA-binding protein that is essential for growth in M. tuberculosis, other mycobacteria
(10–12). Furthermore, CarD is required for the response
of Mtb to oxidative stress, some antibiotics and infection
of mice (10). In vitro, CarD binds to initiation complexes
and stimulates the production of RNA by stabilizing the
relatively unstable RPo generated by mycobacterial RNAP
holoenzyme on ribosomal promoters (11,12,16). In initiation complexes, it makes direct molecular interactions with
the ␤1 lobe of the RNAP ␤ subunit through its N-terminal
RNAP-interaction domain (RID) (10,17,18) (Figure 1A
and B). CarD also binds DNA non-specifically through
its C-terminal domain (CTD) (19, Srivastava: 2013ga; 20),
which contains a tryptophan residue that interacts with
the upstream edge of the transcription bubble to stabilize
RPo (18). Mutations in the RID, CTD or tryptophan lead
to distinct in vivo and in vitro effects suggesting that full
CarD activity requires each of these three functional modules (12,17,20). Based on these studies and previous analyses by our group, our working model for how CarD stabilizes open complex and stimulates transcription consists
of a two-tiered, concentration-dependent mechanism. The
model predicts that at low concentrations (i.e. <100 nM),
CarD binds RPo and slows the rate of bubble collapse by
conformational selection, while at higher concentrations,
CarD binds RPc and accelerates the rate of DNA unwinding by induced fit (12). We expect both of these kinetic effects to play roles in vivo where the concentration of CarD
is well in excess of 100 nM (12).
RbpA is also an essential RNAP- and DNA-binding protein found in M. tuberculosis and other Actinobacteria, but
not in E. coli (13,15). RbpA consists of an unstructured Nterminal tail, a central core ␤-barrel domain, a 15 amino
acid basic linker (BL) and a C-terminal sigma-interacting
domain (SID) (15,21) (Figure 1A). The SID binds to the
second domain of sigma ( 2 , domains 1.2, 2.3 and the nonconserved region) in both the presence and absence of the
core RNAP enzyme and has specificity to the housekeeping sigma factor  A and the stress-response sigma factor
 B (15,21,22). A crystal structure of a BL/SID construct
bound to  A 2 has been solved (15) and can be used to position RbpA in the initiation complex (Figure 1B). RbpA’s
sigma specificity has led to proposals that RbpA plays a role
in the competition of sigma factors for RNAP core (14,23).
RbpA potentially stabilizes RNAP holoenzyme by binding
both sigma and either ␤2 or another region of the core subunits (14,15). Furthermore, RbpA can increase the affinity
of holoenzyme to the promoter, presumably via the interaction of the BL with DNA (15,24). An arginine residue (R79)
in the BL is thought to play a role in RbpA’s ability to bind
DNA, although it is unknown whether this interaction may
contribute to RbpA’s promoter specificity (15). RbpA stimulates transcription in vitro and the BL/SID region of the
protein are sufficient for partial stimulation (15). However,
the mechanism of transcriptional stimulation by RbpA remain unclear.
Here, we perform a mechanistic analysis of the function
of Mtb RbpA during open complex formation on the Mtb

rrnAP3 promoter using a real-time fluorescence assay (25)
and show that RbpA stabilizes open complex. Furthermore,
RbpA accelerates the approach to equilibrium providing insight into the kinetic mechanism at play. Interestingly, this
trend is qualitatively distinct from that of CarD, suggesting that the two factors function in fundamentally different
ways.
Furthermore, stopped-flow fluorescence experiments
performed in the presence of both factors reveal positive
linkage between the effect of CarD and RbpA on RPo stability at the Mtb rrnAP3 promoter. The observation that
the two factors bind cooperatively demonstrates for the first
time that RbpA and CarD can act on the same initiation
complex simultaneously. This is consistent with the prediction that CarD and RbpA have distinct binding sites on
initiation complexes (15,18). We present a thermodynamic
analysis to quantitatively describe the positive linkage between the two factors. Lastly, we observe a dramatic acceleration in observed rates when both factors are present, and
the approach to equilibrium under these conditions resembles that of E.coli RNAP acting on the same promoter.
The data and analysis presented here reveal important
details regarding the mechanistic differences between CarD
and RbpA and provide a kinetic framework for the function
of these two essential mycobacterial transcription factors
both independently and cooperatively. This work brings us
a step closer to understanding the functional logic of transcription regulation in a pathogenic bacteria that represents
a significant burden to human health worldwide.

MATERIALS AND METHODS
Protein purification
Mbo RNAP, Mbo  A and Mtb CarD were prepared as previously described (12). Mtb RbpA was cloned into a pETSUMO-His6 vector and introduced into E. coli BL21(DE3)
cells. After growth at 37◦ C to an OD600 of 0.8, protein overexpression was induced by the addition of 1 mM Isopropyl
␤-D-1-thiogalactopyranoside (IPTG). The tagged protein
was purified by nickel affinity chromatography (HP HiTrap,
GE Healthcare) and the SUMO tag was cleaved overnight
with His-tagged Ulp1 protease. Pure untagged RbpA was
collected in the flow through of a second nickel affinity column. The protein was stored in 20 mM Tris (pH 8.0), 150
mM NaCl and 1 mM beta-mercaptoethanol at −80◦ C.

Promoter DNA
A total of 150 base-pair Mtb rrnAP3 promoter fragments
with a Cy3 label on the +2 non-template dT were prepared
as previously described (12), with one notable exception:
residues flanking the promoter sequence were replaced with
those native to the Mtb genome (H37Rv coordinates 1 471
577–1 471 727, Supplemental Sequence) (26,27). Control
experiments indicated that this change had no effect on previously published results describing the effect of CarD on
open-complex stabilization on the same promoter with random flanking sequence (12).
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Figure 1. Mycobacterial transcription factors and a fluorescence assay for following open complex formation. (A) CarD is made up of an N-terminal
RNAP-interaction domain (RID, light blue) and a C-terminal DNA-binding domain (dark blue). RbpA consists of a core domain (white), a basic linker
domain (BL) and a sigma-interacting domain (SID, red). (B) Ribbon representations of both factors are shown in the context of an open complex structure.
Both domains of CarD and the SID of RbpA are modeled together based on the structure of CarD bound to open complex (4XLS (18)) and the structure
of the RbpA SID domain bound to domain 2 of  A (4X8K (15)). (C) Fluorescence assay for following the formation of open complexes. A Cy3 fluorophore
attached to the +2 non-template dT undergoes fluorescence enhancement upon open-complex formation.

Stopped-flow fluorescence assay
The stopped-flow assay was performed as previously described (12). In brief, Mbo RNAP core was mixed with 3- to
6-fold molar excess Mbo  A at 25◦ C to form holoenzyme.
Holoenzyme was mixed with transcription factor(s) or an
equivalent volume of transcription factor storage buffer
such that the proteins were initially at twice the desired final
reaction concentrations. Promoter DNA was also prepared
at twice the desired final reaction concentration. Equal volume mixing was performed in a stopped-flow apparatus
(Applied Photophysics SX-20, total shot volume 150 l,
dead time < 2 ms), so the initial protein and DNA solutions
were each diluted by half in order to reach their final reaction concentrations. All experiments were performed using
a final MboRNAP holoenzyme concentration of 225 nM
and a DNA concentration of 10 nM unless otherwise noted.
Excitation light was provided by a 510 nm LED light source,
as opposed to a 515 nm light source from an arc lamp passed
through a monochromator. Emission was collected at 570+
nm using a long-pass filter. Control experiments indicated
that this subtle change in excitation wavelength had no effect on previously published results describing the effect of
CarD on mycobacterial open-complex stabilization. All experiments were performed at 25◦ C in the following final solution conditions: 14 mM Tris pH 8.0, 120 mM NaCl, 10
mM MgCl2 , 1 mM DTT, 0.1 mg/ml BSA and 10% glycerol
by volume.
Two to three traces were collected per condition. Traces
for each condition were averaged and plotted as fold-change
over DNA by first subtracting the buffer signal from all
traces and then plotting the data as (F−F0 )/F0 , where F0 is

the signal for DNA alone and F is the signal for DNA mixed
with protein. The fold-change traces were fit to a triple exponential from 0.1–1200 s using the ProData Viewer software from Applied Photophysics:
F(t) =

3


Aobs,i · e−kobs,i t

(1)

i =1

where Aobs,i and kobs,i are the amplitude and observed rate of
the ith kinetic phase. To facilitate consistency in assignment
of fast, intermediate and slow phases, traces were anchored
to the intermediate and slow phases using either a single or
double exponential before fitting the fast phase of the trace.
Fractional amplitudes were calculated according to:
Aobs,i
A f r c,i =  N
i =1 Aobs,i

(2)

In order to estimate an overall rate for the approach to
equilibrium, an amplitude-averaged rate was calculated using the intermediate and slow phases according to:
kobs =

(Aobs,2 · kobs,2 ) + (Aobs,3 · kobs,3 )
Aobs,2 + Aobs,3

(3)

Conditions that were repeated multiple times on different days were used to estimate standard error of the mean
(SEM). An average SEM was used to estimate uncertainty
for specific conditions that were only repeated multiple
times on the same day to better estimate the actual error
for these points.
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In vitro aborted transcription assay
CarD and RbpA used in this assay were diluted into 1×
dialysis buffer (20 mM Tris pH 8.0, 150 mM NaCl and
1 mM BME). Mbo  A was mixed in 8-fold molar excess
with core RNAP to reconstitute the RNAP holoenzyme.
A total of 85 bp overlapping primers (IDT) were annealed
and extended to prepare a linear fragment of dsDNA Mtb
Erdman strain genomic DNA containing nucleotides 1 470
151 to 1 470 300 which includes the Mtb rrnAP3 promoter.
The final reaction conditions were: 225 nM Mbo  A -holo
RNAP, 1–2 M CarD or equivalent volume of buffer, 1–
2 M RbpA or equivalent volume of buffer, 10 nM linear
DNA template, 210 M GpU dinucleotide, 21 M UTP,
0.1 L [␣ - 32 P]-UTP, 14 mM Tris pH 8.0, 100 mM NaCl,
10.2 mM MgCl2 , 5% (vol/vol) glycerol, 1 mM DTT and 0.1
mg/ml BSA (NEB) in a total volume of 20 l. Mbo core
and  A were incubated for 10 min at room temperature.
CarD, RbpA and/or dialysis buffer were added to the polymerase and the proteins were incubated for 10 more minutes
at room temperature. The DNA template was added and the
reactions were diluted to 17.5 l, followed by an additional
10 min at room temperature. Reactions were initiated with
addition of a 2.5 l mixture containing GpU, UTP and the
radiolabeled UTP. After 20 min incubation at room temperature, the reactions were stopped with 2x formamide buffer
[98% (vol/vol) formamide, 5 mM EDTA] and run on a 22%
urea PAGE gel.

RESULTS
RbpA stabilizes rrnAP3 open complexes
To study the effect of RbpA on transcription open complexes (RPo ) we used a fluorescence assay that reports on
RPo formation in real-time as previously reported (12,25).
For these experiments, we use M. bovis (Mbo) RNAP which
is virtually identical to MtbRNAP differing only in the
69th amino acid of the ␤’ subunit which is a proline in
MboRNAP and an arginine in MtbRNAP. A stopped-flow
apparatus was used to mix Mbo  A -saturated MboRNAP
with Cy3-labeled Mtb rrnAP3 promoter, and fluorescence
intensity was monitored over time. The dye is conjugated
to the +2 non-template thymine and exhibits enhanced fluorescence intensity upon RPo formation, providing a way
to measure the kinetics of open complex formation as well
as the amount of open complex at equilibrium (Figure 1C).
Several control experiments support our interpretation of
Cy3 fluorescence enhancement as a reporter of promoteropening. First, promoter-less templates do not show fluorescence enhancement, demonstrating sequence dependence (12). Second, experiments performed at 10◦ C, 25◦ C
and 37◦ C showed increasing fluorescence enhancement by
RNAP with increasing temperature, consistent with the
known temperature dependence of promoter-melting (12).
Third, at high concentrations of RNAP, where promoters
are saturated with holoenzyme, CarD leads to a large fluorescence enhancement showing that CarD specifically affects a step after holoenzyme binds the promoter (i.e. promoter opening). Lastly, the CarD-dependent fluorescence
enhancement follows the same trend of open-complex stabi-

Figure 2. RbpA and CarD stabilize open complex. (A) Fluorescent foldchange is plotted over time from mixing MboRNAP and Mtb factors with
a +2 T Cy3-labeled Mtb rrnAP3 promoter template. DNA alone mixed
with buffer (black), a titration of RbpA from 0–2 M (red) and 1 M
CarD (blue) are shown. (B) The equilibrium fluorescence fold change
over 225 nM RNAP alone is plotted versus the concentration of either
RbpA (red) or CarD (blue). The data are fit with the binding model
A*[factor]/([factor]+Keff ) to extract amplitudes (ACarD = 6.1 ± 0.1 and
ARbpA = 2.9 ± 0.1) and effective binding constants (Keff,RbpA = 177 ± 23
nM and Keff,CarD = 73 ± 4 nM). Two to three shots were collected for each
condition and error bars represent standard error of the mean.

lization observed in potassium permanganate experiments
(12,16).
Incubating MboRNAP with increasing concentrations
of wild-type RbpA results in increasing equilibrium fluorescence, demonstrating that RbpA stabilizes RPo at the
rrnAP3 promoter (Figure 2A). The R79A mutant of RbpA,
which is known to play an important role in transcriptional
activation (15), results in approximately half the increase in
equilibrium fluorescence when added at a concentration at
which WT RbpA saturates (2 M, Supplementary Figure
S1). A fit of the equilibrium fluorescence fold-change generated by WT RbpA normalized to RNAP alone to the binding isotherm 1 + A*[RbpA]/([RbpA]+Keff ) gives a value of
the concentration of half-maximal effect, Keff = 177 ± 23
nM. This Keff is approximately 2-fold weaker than that of
CarD (73 ± 4 nM). At saturation, RbpA produces ∼3 times
(A = 2.9) more fluorescence enhancement than MboRNAP
alone, compared to CarD which saturates at ∼6-fold (A =
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6.1) over RNAP (Figure 2B). Assuming equilibrium fluorescence enhancement correlates with the extent of RPo stabilization, the lower equilibrium fluorescence generated by
RbpA at saturation suggests that RbpA stabilizes RPo to a
lesser extent than CarD. However, given that Cy3 fluorescence enhancement is sensitive to local changes in the dye’s
microenvironment, we do not exclude the possibility that
the assay reports on multiple open complexes, each with
subtle conformational differences leading to different fluorescence enhancements. With this in mind, it is possible
that the RbpA-stabilized RPo produces lower fluorescence
enhancement than the RPo stabilized by CarD. If this were
the case, the extent of fluorescence enhancement would not
correspond to the extent of open complex stabilization, but
instead would report on the average fluorescence enhancement of an ensemble of open complexes. Clearly, the difference in fluorescence enhancements contains information
regarding the mechanisms of open complex stabilization by
the two factors. Here, we can only speculate on the molecular details that lead to the observed enhancements, however,
these details do not impact the conclusions drawn from the
analyses that follow.
RbpA stabilizes open complexes through a different kinetic
mechanism than CarD
Although RbpA and CarD are unique proteins that bind
the transcription initiation complex at distinct sites, the two
factors share several important structure-function properties. Specifically, both factors bind RNAP-holoenzyme and
DNA, and both factors stabilize RPo . For these reasons,
we considered the possibility that RbpA stabilizes opencomplexes using a similar kinetic mechanism as CarD (12).
Curves in the presence of either RpbA or CarD were well-fit
by a triple exponential (see Materials and Methods) and the
phases were separable by approximately an order of magnitude. The low fractional amplitude of kobs,1 made it challenging to measure, so we cannot exclude the possibility that
RbpA or CarD influence the kinetics of the fastest observed
phase.
We observed dramatic differences between RbpA and
CarD in the intermediate and slow phases. CarD traces
are dominated by the slowest phase (kobs,3, ), whereas RbpA
traces contain significant contributions from both the intermediate and slowest phases (kobs,2 and kobs,3 , respectively)
(Supplementary Figure S2). Analysis of the trends in the observed rates themselves also indicated differences between
RbpA and CarD (Figure 3B and C). We observe monotonic
and saturable increases in kobs,2 and kobs,3 with increasing
RbpA concentration (Figure 3B). Conversely, we were unable to discern a systematic trend in kobs,2 as a function of
CarD concentration (Figure 3B). Furthermore, kobs,3 displays a non-monotonic trend with increasing CarD concentration (Figure 3C and Supplementary Figure S3). Thus,
RbpA accelerates the approach to equilibrium at all concentrations tested while CarD decelerates equilibration at low
concentrations and accelerates equilibration at high concentrations.
We considered the mechanistic implications of the distinct kinetic trends observed for RbpA and CarD. CarD’s
non-monotonic trend in kobs,3 can be explained in the con-

Figure 3. Concentration dependence of observed rates. (A) The intermediate phase of stopped-flow time courses is different between RbpA and
CarD. For RbpA (red), kobs,2 increases in a monotonic and saturable
manner with increasing concentration. For CarD, kobs,2 , does not show
any systematic concentration dependence. (B) RbpA and CarD exhibit
different concentration-dependent trends in kobs,3 . The slowest phase of
time courses increases monotonically with increasing RbpA concentration
(red), unlike CarD (blue), which decelerates at low concentrations and accelerates at higher concentrations. Two to three shots were collected for
each condition and error bars represent standard error of the mean.

text of a two-step reversible model coupled to factor binding (12) (Supplementary Figure S4A). However, the observation of multiple saturable observed rates in the presence of RbpA demonstrates that the simple two-step reversible mechanism of open complex formation cannot account for the observed kinetics. Therefore, our data suggest that the mechanism of RpbA open complex stabilization must involve more states. Since RbpA is known to bind
sigA, RNAP core and holoenzyme, one possibility is that
RbpA’s protein-binding interactions contribute to the observed kinetics (Supplementary Figure S4B). Another possibility is that RbpA interacts with additional intermediates on pathway to RPo (Supplementary Figure S4B). These
possibilities are not mutually exclusive, and a detailed anal-
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ysis of the kinetic mechanism of RbpA’s stabilization of RPo
remains an active area of investigation.
RbpA and CarD cooperatively stabilize open complex
As each factor stabilizes RPo and structural modeling suggests that they could both bind RP complexes concurrently
(15), we tested the effect of RbpA and CarD together on
open-complex stability. Since RbpA generates a lower fluorescence enhancement compared to CarD, we reasoned that
if RbpA competed with CarD for binding to the initiation
complex, the addition of both factors would lead to an intermediate enhancement. However, in the presence of both
factors at saturating concentrations, the equilibrium fluorescence fold change is actually greater than that for saturating CarD alone (Figure 4A).
If RbpA and CarD bind concurrently to the rrnAP3
promoter-RNAP complex, one expects to measure positive
linkage or cooperativity between the two factors as both
stabilize the same conformation, namely open complex. To
test this model, we performed titrations of each factor in the
presence of the other factor at saturation and asked whether
we observed a shift in Keff relative to each factor alone. Indeed, titrating RbpA in the presence of 1 M CarD results
in a Keff (48 ± 10 nM) that is lower than that obtained from
a titration of RbpA alone (177 ± 23 nM), suggesting that
the presence of CarD increases the binding affinity of RbpA
to transcription initiation complexes (Figure 4B). Likewise,
a CarD titration in the presence of 2 M RbpA results in a
Keff (16 ± 2 nM) that is lower than a titration of CarD alone
(73 ± 4 nM), indicating that the presence of RbpA allows
CarD to interact with the complex at lower concentrations
(Figure 4C). This observation of heterotropic, positive linkage between RbpA and CarD demonstrates that they act
cooperatively on transcription initiation complexes at the
Mtb rrnAP3 promoter.
To provide an overall quantification of the observed linkage, we consider the thermodynamic cycle involving four
states: (i) RP, (ii) RP-CarD, (iii) RP-RbpA and (iv) RPRbpA-CarD, where RP represents promoter-bound RNAP
and includes an ensemble of states (i.e. RPc , RPo and all
intermediates) (Figure 4D). We globally fit the four experimental binding curves (CarD titrations ± 2 M RbpA and
RbpA titrations ± 1 M CarD) to a model where each factor has an effective affinity (Keff ) and linkage is captured
by the cooperativity factor ␣ (Supplementary Figure S5).
In the context of this model, the effective affinity of a factor in the presence on the other is given by Keff /␣. A fit of
the data with this three-parameter model results in values
of Keff,CarD = 66 ± 7 nM, Keff,RbpA = 175 ± 20 nM and ␣ =
3.8 ± 0.4. All four Keff values are within error of the values
obtained from fits of the individual titrations alone. Thus, a
simple model of cooperativity captures the positive linkage
between RbpA and CarD at initiation complexes.
Given that RbpA and CarD cooperatively stabilize open
complex, we hypothesized that they would also stimulate
transcription above the level of either factor acting alone.
To test this hypothesis, we performed an aborted transcription assay in which we measured the production of a three
nucleotide transcript from the rrnAP3 using a dinucleotide
primer (GpU) and a radio-labeled UTP. RbpA and CarD

acting individually at saturating concentrations stimulate
transcription of the 3-nt product over RNAP alone (Supplementary Figure S6). The presence of both factors results in a
further increase in 3-nt production over either factor acting
alone. These results are consistent with a model in which
CarD and RbpA cooperatively stabilize a transcriptioncompetent open complex.
RbpA and CarD act together to accelerate the approach to
RPo equilibrium
To identify any cooperative kinetic effects stemming from
the presence of both RbpA and CarD on open complex
equilibration, we used a triple exponential to fit the raw data
traces and examined the manner in which the observed rates
(Figure 5B and C) and the fractional amplitudes (Supplementary Figure S7) depended on transcription factor concentration with both factors present.
Compared to RbpA and CarD individually, we found
that kobs,2 and kobs,3 were faster when both factors were
present. While the presence of CarD did not affect the dependence of the observed rates on RbpA concentration, the
presence of RbpA did affect the dependence of the observed
rates on CarD concentration. Titrations of CarD performed
in the presence of RbpA at saturation indicated that both
kobs,2 (Figure 5B) and kobs,3 (Figure 5C) now increase in a
saturable and monotonic manner. This trend is quite different than what is observed for CarD titrations performed in
the absence of RbpA, in which kobs,2 does not exhibit a discernible trend, and kobs,3 exhibits non-monotonic behavior.
To facilitate a general kinetic comparison of RbpA and
CarD acting individually and together, we calculated an
amplitude-averaged rate as a means to quantify an overall, apparent rate of open-complex equilibration (Materials
and Methods). This analysis supports the conclusion that
open-complex equilibration is faster in the presence of both
factors (Figure 6). Specifically, the averaged rate (k<obs> )
observed with saturating concentrations of both factors is
at least 3 times faster than in the presence of either factor alone. Interestingly, the presence of both factors leads
to traces with similar kinetics and equilibrium fluorescence
to those obtained using the RNAP holoenzyme from E. coli
(Figure 7).
DISCUSSION
We have presented a study of RbpA and CarD acting individually and together to stabilize mycobacterial transcription open complexes. Like CarD, we found that RbpA stabilizes RPo at the Mtb rrnAP3 promoter, albeit via a different kinetic mechanism. Using a stopped-flow fluorescence
assay that reports on open-complex formation in real time,
we observed that, compared to CarD, RbpA generates a
lower equilibrium fluorescence at saturating concentrations
and has a weaker apparent affinity for initiation complexes.
In addition, RpbA exhibits two observed rates (kobs,2 and
kobs,3 ) with appreciable fractional amplitudes in contrast
to the one dominant observed rate (kobs,3 ) detected in the
presence of CarD. The magnitudes of both of these rates
show monotonic and saturable acceleration with increasing
RbpA concentration. These results all suggest that the ki-
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Figure 4. RbpA and CarD bind to initiation complexes cooperatively. (A) Fluorescent fold change as a function of time for DNA alone (black), MboRNAP
alone (green), 2 M RbpA (red), 1 M CarD and 2 M RbpA + 1 M CarD (magenta). (B) Normalized fluorescence fold-change as a function of RbpA
concentration in the absence (red) and presence (magenta) of 1 M CarD. (C) Normalized fluorescence fold-change as a function of CarD concentration
in the absence (red) and presence (magenta) of 2 M RbpA. (D) A thermodynamic cycle between apo-RP, CarD-bound RP, RbpA-bound RP and the
doubly-bound RP. Here, RP represents the total population of DNA-bound polymerase and includes RPc and RPo . The four titrations shown in (B) and
(C) were globally fit with three parameters: Keff,CarD , Keff,RbpA and a cooperativity factor ␣ which relates the ratio of Keff of a factor in the presence and
absence of the other. The fits are shown in (B) and (C) along with the values for Keff . The fit cooperativity factor, ␣ = 3.8 ± 0.4, corresponds to a G =
–RTln(␣) = −3.3 kJ/mol (−0.8 kcal/mol). Two to three shots were collected for each condition and error bars represent standard error of the mean.

netic mechanism by which RbpA stabilizes mycobacterial
open complexes is distinct from that of CarD.
A two-step reversible model (R+P ↔ RPc ↔ RPo ) can
capture the kinetics of open complex formation under certain conditions. However, this model is almost certainly
an over-simplification of the real mechanism. For example, we have shown that kinetic traces of open complex formation by MboRNAP alone exhibit three observed rates
which cannot be accounted for in the context of the twostep reversible model. Furthermore, the kinetic mechanism
of open-complex formation by E. coli RNAP includes multiple closed and open intermediates (1,28–30) and transcription with mycobacterial RNAP has previously been analyzed with E. coli derived models (31). Therefore, the kinetic mechanism of mycobacterial open complex formation
likely involves intermediates between the initial closed complex and the final transcription-competent open complex.
We hypothesize that the distinct kinetic signatures of RbpA
and CarD are due, in part, to their differential affinities with
these intermediates. Furthermore, intermediate open complexes may have different fluorescence properties leading

to the differential enhancements observed between RbpA
and CarD. Another possible way to expand the two-step
reversible model to account for the complexity of the observed kinetics is to add the interaction of these factors with
free polymerase in the absence of DNA. RbpA is known to
bind sigma factor, core RNAP and holoenzyme (14,15,22)
and CarD binds to RNAP (10,18,19). In light of these possibilities, analysis using kinetic models that include multiple intermediates and DNA-independent assembly states
remains an ongoing research direction (Supplementary Figure S4B).
In addition to studying each factor individually, we performed experiments using both RbpA and CarD together.
Stopped-flow titrations indicated that the presence of one
factor increases the apparent affinity of the other factor to
the RNAP-promoter complex, demonstrating positive linkage between the two factors. The observation of positive
linkage demonstrates that not only can CarD and RbpA
bind the initiation complex simultaneously, but also that
they do so cooperatively. Cooperativity between transcription factors has been observed for transcription initiation
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Figure 6. The kinetics of equilibration are accelerated by the presence of
both factors. An amplitude-averaged rate is plotted as a function of factor
concentration for RbpA titrations (red) and CarD titrations (blue) and in
the absence (solid lines) and presence (dashed lines) of the other factor at
saturation. Two to three shots were collected for each condition and error
bars represent standard error of the mean.

Figure 5. Kinetic effects of cooperative stabilization. (A) The intermediate
phase (kobs,2 ) increases monotonically with concentration for either RbpA
titrated in the presence of CarD (red) or CarD titrated in the presence of
RbpA (blue). (B) The slowest phase (kobs,3 ) increases monotonically with
concentration for either RbpA titrated in the presence of CarD (red) or
CarD titrated in the presence of RbpA (blue). Two to three shots were
collected for each condition and error bars represent standard error of the
mean.

(32–34), elongation (35) and termination (36). This cooperativity can lead to activation or repression and affords
complexity and tunability to gene regulation (37). Furthermore, cooperativity amongst transcription factors can occur between the same factors (homotropic) or different factors (heterotropic) (32–34). In Mtb specifically, cooperative
binding of DevR factors to their DNA sites plays a role
in the activation of a regulon required for the induction of
dormancy in response to hypoxic conditions (38,39). However, to our knowledge the cooperative association of RbpA
and CarD is the first example of heterotropic cooperativity
between transcription factors that directly bind initiation
complexes to stabilize open complex.
When speculating about the mechanism of cooperativity
between RbpA and CarD, we consider two general possibilities that are not mutually exclusive: (i) a ‘direct’ mechanism
in which RbpA and CarD physically interact, so that the

presence of one factor provides an additional binding surface for the other; and (ii) an ‘allosteric’ mechanism where
the binding of one factor results in conformational changes
in the initiation complex that lead to higher affinity binding of the second factor (i.e. conformational selection). Although a ‘direct’ interaction between RbpA and CarD is
not predicted by structural modeling, we do not exclude the
possibility that direct interactions between the two factors
contribute to the observed positive linkage. In particular,
the location of RbpA’s core domain in the initiation complex is unknown and predicted to be in close proximity to
the C-terminal domain of CarD. The allosteric mechanism,
however, must contribute to the observed positive linkage
through conformational selection of RPo . RbpA and CarD
each must have a higher affinity to RPo than to RPc as they
both stabilize RPo . Thus, the binding of one factor shifts
the population of initiation complexes to the higher affinity
open-complex conformation(s), resulting in a lower Keff for
the other factor. Whether the allosteric mechanism of conformational selection accounts for all or just some of the
positive linkage remains an active area of investigation.
When studying the effect of both factors acting together
on the kinetics of open-complex equilibration, we noticed
a substantial acceleration in kobs,2 and kobs,3 , demonstrating
that the overall approach to equilibrium is faster compared
to either factor acting alone (Figures 5 and 6). Based on this
observation, we hypothesize that the interactions of both
factors with the initiation complex accelerate distinct forward rates on the pathway to open-complex formation. The
pathway to open complex determined with the E. coli system involves many structural intermediates including DNA
bending and wrapping, DNA unwinding and loading of the
template strand, assembly of the clamp/jaw domains and
closing of the clamp/jaw domains around the downstream
DNA (1,30). More specifically, the bending of downstream
duplex into the polymerase cleft has been linked with the
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and cooperatively on open-complex formation at the Mtb
rrnAP3 promoter. We expect the work presented here to
provide a quantitative framework that can be used to develop mechanistic models of RbpA and CarD. We hypothesize that the concurrent binding and positive linkage between these essential transcription factors play important
roles in mycobacterial gene regulation in that they result
in (i) the more efficient recruitment of transcription factors to initiation complexes and (ii) the rapid formation of
a more stable open complex. Further studies are needed to
describe the detailed kinetics of both factors on all phases of
transcription initiation to understand their overall effect on
transcriptional flux at promoters throughout the mycobacterial genome.
Figure 7. The kinetics of open complex formation for MboRNAP in the
presence of RbpA and CarD resemble those for EcoRNAP on the rrnAP3
promoter. Fluorescence time courses collected with RbpA and CarD (solid
red) dramatically increase the fluorescence signal at equilibrium and accelerate the kinetics compared to RNAP alone (green). The kinetics of
MboRNAP with RbpA and CarD approaches that of 85 nM EcoRNAP
(dashed red), which equilibrates to the same fluorescence fold-change (1.4).

nucleation of DNA melting (30). The basic linker of RbpA
interacts with the extended −10 motif (15) and tryptophan
85 in CarD’s DNA-binding domain interacts with the upstream edge of the transcription bubble at the junction between the double-stranded −12 base-pair and the singlestranded −11 position (11,18), precisely where nucleation of
promoter melting occurs (Figure 1B). Taken together, these
structural considerations suggest the possibility that RbpA
and CarD cooperate to facilitate promoter bending and nucleation of promoter-melting. This combined mechanism of
RbpA and CarD may be similar to the induced-fit mechanism of bending and opening used to describe the effect
of the transcription factor Mtf1 on mitochondrial opencomplex kinetics (40). Importantly, this model is also compatible with the proposed conformational-selection mechanism in which CarD acts to prevent bubble collapse after
the promoter DNA has been opened (11,12,18).
We also show that RbpA and CarD jointly lead to
transcriptional dynamics for MboRNAP similar to E. coli
RNAP (Figure 7). This result leads us to speculate that
RbpA and CarD play the role of general transcription factors for Mtb, at least at housekeeping  A -dependent promoters. In light of the cooperativity between the two factors,
the preference of RbpA (14,22) for  A and  B holoenzymes
and the presumed sigma-independence of CarD raise interesting questions regarding the regulatory logic behind each
of these essential factors. For example, the cooperativity
may provide a mechanism for the preferential recruitment
of CarD to RbpA-dependent promoters. Alternatively, the
association of CarD with other sigma factors may lead to
RbpA binding at non- A or  B promoters. In addition, our
data predict that the overall effect on open complex equilibrium at initiation complexes containing both factors will be
greater than those containing either factor alone. This effect
could lead to the different regulatory outcomes depending
on which factors are present at specific promoters.
In summary, we describe the kinetics and concentration dependencies of RbpA and CarD acting individually
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